FIND YOUR HAPPINESS
LIVE

Serial Number

98812458

Owner

GUUD AG

Attorney

Vivian Ortiz-Ponce

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FIND YOUR HAPPINESS Trademark

Serial Number: 98812458

FIND YOUR HAPPINESS is a trademark filed by GUUD AG on October 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

GUUD AG (4 trademarks)

Gartenstrasse 4
Zurich 6300 , CH

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Pharmaceutical products for use in the treatment of metabolic syndrome, obesity and overweight; preparations for medical and veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; hygienic products in the nature of disinfectants and sanitary preparations for medical use in the treatment of metabolic syndrome, obesity and overweight; dietetic food and beverages adapted for medical or veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; food supplements for persons or animals; capsules for medicines, sold empty for pharmaceuticals; medicines for constipation, dragées being medicated confectionery, for use in the treatment of metabolic syndrome, obesity and overweight; non-steroidal anti-inflammatory medicines for use in the treatment of metabolic syndrome, obesity and overweight; anti-fungal medicines; anti-malarial medicines; anti-pyretic medicines; Medicated soap for perspiration; anti-tumor medicines; antitussive medicines; cytostatic medicines for medical use; allergy medicines; diarrhea medicines; non-prescription medicines for use in the treatment of metabolic syndrome, obesity and overweight; medicines for adjusting the menstrual cycle; medicine for alleviating allergies; medicines for alleviating pain; acne medicines; medicines for alleviating burns; medicines for the treatment of gastrointestinal diseases; medicines for the prevention of puerperal fever; cough alleviating medicines; medicines for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for dental use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for veterinary use for use in the treatment of metabolic syndrome, obesity and overweight serotherapeutic medicines; transdermal patch with medicine featuring preparations for the treatment of metabolic syndrome, obesity and overweight; patches impregnated with medicinal preparations for the treatment of metabolic syndrome, obesity and overweight; sulfonamide preparations; tonics, namely, medicinal drinks; medicines for alleviating constipation; diagnostic agents for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; milk ferments for pharmaceutical use; mixed hormone preparations for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; sunburn products for pharmaceutical use for treating sunburn; capsules for pharmaceutical use, sold empty for pharmaceuticals; tablets for pharmaceutical use, being capsules sold empty for pharmaceuticals; amino acid preparations for medical purposes; analgesics for pharmaceutical use; bacteriological preparations for medical and veterinary purposes; medicated body creams for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicated skincare preparations in the nature of body gels for medical use for use in the treatment of metabolic syndrome, obesity and overweight

Downloadable mobile device applications for use in telemedicine, purchasing pharmaceutical products and creating medical content; Downloadable software applications for mobile telephones for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable applications for use with mobile devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; Downloadable software and applications for mobile devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable mobile applications for use with portable computer devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable mobile applications for use in information management; Downloadable computer application software for mobile phones for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable software as a medical device for diagnosing and treating of metabolic syndrome, obesity and overweight in the field of telemedicine, and also for use in purchasing pharmaceutical products and creating medical content related thereto; Downloadable computer programs relating to the medical field for use in telemedicine, purchasing pharmaceutical products and creating medical content; scales

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jul 31, 2026 EX1G
SOU EXTENSION 1 FILED
Jul 31, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 31, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 11, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 6, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 6, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2025 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2025 REAP
ASSIGNED TO EXAMINER
Apr 23, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2025 NWOS
NEW APPLICATION ENTERED
Oct 21, 2024 NWAP